Results 211 to 220 of about 98,417 (285)

The Prognostic Value of Serum Inflammatory Markers in Nasopharyngeal Carcinoma Patients Treated With Immune Checkpoint Inhibitors: A Multicenter Study

Cancer Medicine, Volume 15, Issue 6, June 2026.
ABSTRACT Background Although immune checkpoint inhibitors (ICIs) have revolutionized the treatment of nasopharyngeal carcinoma (NPC), reliable predictive biomarkers need to be further explored. This study aimed to investigate the predictive ability of inflammatory markers for poor prognosis in NPC patients treated with ICIs. Methods In this multicenter
Yang Xu, Jingyi Xie, Danmeng Zhang, Liru Zhu, Xiaojun Chen, Qingqing Zhang, Haoyu Lv, Kaihua Chen, Ling Li, Song Qu, Xishan Chen, Wenqi Liu, Xiaodong Zhu   +12 more
wiley   +1 more source

Is FOLFIRINOX more effective than gemcitabine plus nab-paclitaxel in pancreatic adenocarcinoma? -a decade of debate! [PDF]

J Gastrointest Oncol
Babiker HM.
europepmc   +1 more source

Acute Upper Gastrointestinal Bleeding is Associated With Poor Prognosis in Patients With Biliary Tract Cancer

Cancer Medicine, Volume 15, Issue 6, June 2026.
ABSTRACT Aim Upper gastrointestinal bleeding (UGIB) is associated with an unfavorable outcome in cancer patients. In patients with biliary tract cancer (BTC), data on the incidence, management, and prognostic implications of UGIB are limited. This study investigated the prevalence, treatment efficacy, and prognostic factors associated with UGIB in BTC.
Jan Christoph Schumacher, Sonja Lang, Philipp Kasper, Anna Martin, Dirk Waldschmidt, Martin Bürger, Ulrich Töx, Christoph Neumann‐Haefelin, Gabriel Allo   +8 more
wiley   +1 more source

Narrative Review of Potential Non-Surgical Treatments for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer. [PDF]

J Clin Med
Kim SH, Gudlavalleti H, Lerner SP.
europepmc   +1 more source

High Sensitivity ctDNA Analysis Using a Novel Panel and NOIR‐SS Technology for Monitoring Advanced Urothelial Carcinoma

Cancer Medicine, Volume 15, Issue 6, June 2026.
ABSTRACT Advanced urothelial carcinoma (aUC) has a poor prognosis, and real‐time monitoring of treatment response remains clinically challenging. Circulating tumor DNA (ctDNA) has emerged as a promising non‐invasive biomarker that may reflect tumor burden and molecular response.
Tetsuya Danno, Seiji Nakamura, Satoru Taguchi, Yoichi Fujii, Taro Teshima, Yusuke Sato, Taketo Kawai, Yukari Kobayashi, Koji Nagaoka, Yumi Ueda, Ryo Matoba, Kazuhiro Kakimi, Haruki Kume   +12 more
wiley   +1 more source

TROPION-Urothelial03: a phase II/III study of datopotamab deruxtecan (Dato-DXd) for locally advanced or metastatic urothelial carcinoma. [PDF]

Future Oncol
Galsky MD, Drakaki A, Basu A, McGregor B, Bedke J, Loriot Y, Kikuchi E, Guo J, Garmezy B, Sridhar SS, Singh P, Koshkin VS, Fleming M, Klauss G, Lin D, Liu C, Apolo AB, Powles T.   +17 more
europepmc   +1 more source

Docetaxel‐Induced Serositis Mimicking Malignant Pleural Effusion

Clinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Pleural effusions are common in patients with cancer. Although their development may signal progressive malignant disease, drug‐induced effusions are a rare and often overlooked cause of exudative pleural effusions. We describe a 50‐year‐old woman with recurrent granulosa cell tumor of the ovary who developed bilateral pleural and pericardial ...
Muhammad Anees, Kevin Chiu, Stephen Goertzen, Carlos A. Jimenez, Saadia A. Faiz   +4 more
wiley   +1 more source

Recent Advances in Pancreatic Cancer and Biliary Tract Cancers: Biology, Biomarkers, and Evolving Systemic Therapy. [PDF]

Int J Mol Sci
Takrori E, Abdulmajid M, Devagudi D, Sohail R, Sadiq Z, Berneau C, Shenouda A, Adelli R, Peshin S, Singal S.   +9 more
europepmc   +1 more source

Hepatocyte growth factor/c‐Met signaling axis in human diseases: Mechanistic insights and therapeutic potential

Journal of Cell Communication and Signaling, Volume 20, Issue 2, June 2026.
Figure 1 visually summarizes the core biological functions and therapeutic potential of the HGF/c‐Met signaling axis. Abstract Hepatocyte growth factor (HGF) is a multifunctional cytokine that activates the tyrosine kinase activity of its specific receptor, c‐Met (mesenchymal–epithelial transition factor).
Hongqin Sun, Hao Shu, Qian Zhang, Jishan Zheng, Yunyan Ma, Dengwang Chen, Jidong Zhang, Tao Song   +7 more
wiley   +1 more source